These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16829303)

  • 1. Human Fc receptors: critical targets in the treatment of autoimmune diseases and transplant rejections.
    Ivan E; Colovai AI
    Hum Immunol; 2006 Jul; 67(7):479-91. PubMed ID: 16829303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fc-receptors as regulators of immunity.
    Nimmerjahn F; Ravetch JV
    Adv Immunol; 2007; 96():179-204. PubMed ID: 17981207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy.
    Binstadt BA; Geha RS; Bonilla FA
    J Allergy Clin Immunol; 2003 Apr; 111(4):697-703. PubMed ID: 12704346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative signaling in Fc receptor complexes.
    Daëron M; Lesourne R
    Adv Immunol; 2006; 89():39-86. PubMed ID: 16682272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.
    Siragam V; Crow AR; Brinc D; Song S; Freedman J; Lazarus AH
    Nat Med; 2006 Jun; 12(6):688-92. PubMed ID: 16715090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell immune response cDNA 7 in allograft rejection and inflammation.
    Utku N; Heinemann T; Milford EL
    Curr Opin Investig Drugs; 2007 May; 8(5):401-10. PubMed ID: 17520869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein in autoimmune diseases.
    Richaud-Patin Y; Soto-Vega E; Jakez-Ocampo J; Llorente L
    Autoimmun Rev; 2004 Mar; 3(3):188-92. PubMed ID: 15110230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc receptors and their interaction with complement in autoimmunity.
    Schmidt RE; Gessner JE
    Immunol Lett; 2005 Aug; 100(1):56-67. PubMed ID: 16125792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
    Tchorbanov AI; Voynova EN; Mihaylova NM; Todorov TA; Nikolova M; Yomtova VM; Chiang BL; Vassilev TL
    Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating and inhibitory Fc gamma receptors in rheumatoid arthritis: from treatment to targeted therapies.
    van Roon JA
    Arthritis Res Ther; 2007; 9(4):106. PubMed ID: 17764583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells.
    Kanazawa N
    J Dermatol Sci; 2007 Feb; 45(2):77-86. PubMed ID: 17046204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The abnormality of FcgammaRIIB1-mediated signaling and the hyperactivity of B cells from patients with systemic lupus erythematosus].
    Peng KJ; Xiao LS; Fei Y; Wang SR
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov; 22(6):769-71. PubMed ID: 17077019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mast cell IgG receptors and their roles in tissue inflammation.
    Malbec O; Daëron M
    Immunol Rev; 2007 Jun; 217():206-21. PubMed ID: 17498061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc gamma receptor biology and systemic lupus erythematosus.
    Jovanovic V; Dai X; Lim YT; Kemeny DM; MacAry PA
    Int J Rheum Dis; 2009 Dec; 12(4):293-8. PubMed ID: 20374365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR; Song S; Siragam V; Lazarus AH
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
    Dejica DI; Manea EM
    Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin receptor agonist, splenectomy and intravenous immunoglobulin for immune thrombocytopaenia with systemic lupus erythematosus.
    Sofue H; Kida T; Seno T; Kohno M; Kawahito Y
    Rheumatology (Oxford); 2018 Aug; 57(8):1495-1497. PubMed ID: 29579273
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future.
    Daëron M; Jaeger S; Du Pasquier L; Vivier E
    Immunol Rev; 2008 Aug; 224():11-43. PubMed ID: 18759918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fc receptor blockade in patients with chronic refractory autoimmune thrombocytopenia].
    Ruiz-Argüelles GJ; Ruiz-Argüelles A; Marín-López A
    Rev Invest Clin; 1993; 45(2):182-3. PubMed ID: 8393212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.